Yahoo奇摩網頁搜尋

- 歌禮宣佈FASN抑制劑ASC40聯合貝伐珠單抗治療復發性膠質母細胞瘤的III期臨床試驗完成120例患者入組
  PR Newswire Asia· 2 天前
  The 2016 World Health Organization classification of tumors of the central nervous system< ...

1
1 個搜尋結果